ATE133960T1 - Peptide mit bradykinin-antagonistischer wirkung - Google Patents

Peptide mit bradykinin-antagonistischer wirkung

Info

Publication number
ATE133960T1
ATE133960T1 AT93400086T AT93400086T ATE133960T1 AT E133960 T1 ATE133960 T1 AT E133960T1 AT 93400086 T AT93400086 T AT 93400086T AT 93400086 T AT93400086 T AT 93400086T AT E133960 T1 ATE133960 T1 AT E133960T1
Authority
AT
Austria
Prior art keywords
peptides
antagonistic effect
bradykinin antagonistic
arg
bradykinin
Prior art date
Application number
AT93400086T
Other languages
English (en)
Inventor
Jean-Luc Fauchere
Christophe Thurieau
Emmanuel Canet
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE133960T1 publication Critical patent/ATE133960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT93400086T 1992-01-17 1993-01-15 Peptide mit bradykinin-antagonistischer wirkung ATE133960T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200438A FR2686343B1 (fr) 1992-01-17 1992-01-17 Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ATE133960T1 true ATE133960T1 (de) 1996-02-15

Family

ID=9425706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93400086T ATE133960T1 (de) 1992-01-17 1993-01-15 Peptide mit bradykinin-antagonistischer wirkung

Country Status (13)

Country Link
US (1) US5409899A (de)
EP (1) EP0552106B1 (de)
JP (1) JPH0730112B2 (de)
AT (1) ATE133960T1 (de)
AU (1) AU653460B2 (de)
CA (1) CA2087379A1 (de)
DE (1) DE69301468T2 (de)
DK (1) DK0552106T3 (de)
ES (1) ES2086195T3 (de)
FR (1) FR2686343B1 (de)
GR (1) GR3019372T3 (de)
NZ (1) NZ245685A (de)
ZA (1) ZA93275B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1996041640A1 (en) * 1995-06-09 1996-12-27 The Regents Of The University Of Michigan Bradykinin analogs as selective thrombin inhibitors
FR2737408B1 (fr) 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE370453C (de) * 1923-03-03 Franz Puening Destillationsverfahren
JPS507057B1 (de) * 1970-10-28 1975-03-20

Also Published As

Publication number Publication date
FR2686343B1 (fr) 1994-03-11
DK0552106T3 (da) 1996-06-24
ZA93275B (en) 1993-08-23
EP0552106A1 (de) 1993-07-21
JPH0730112B2 (ja) 1995-04-05
NZ245685A (en) 1994-07-26
FR2686343A1 (fr) 1993-07-23
CA2087379A1 (fr) 1993-07-18
AU3184493A (en) 1993-07-22
DE69301468T2 (de) 1996-09-05
ES2086195T3 (es) 1996-06-16
AU653460B2 (en) 1994-09-29
DE69301468D1 (de) 1996-03-21
EP0552106B1 (de) 1996-02-07
JPH06179697A (ja) 1994-06-28
US5409899A (en) 1995-04-25
GR3019372T3 (en) 1996-06-30

Similar Documents

Publication Publication Date Title
DE69435105D1 (de) Derivate therapeutischer Peptide
DE69129395D1 (de) Antimikrobielle Peptide
DE4393381T1 (de) Peptide
DE69332485D1 (de) Immunmodulierende peptide
NO170585C (no) Fremgangsmaate for fremstilling av difluorketonpeptidderivater
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
DK6893D0 (da) Peptid
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
DE3689191D1 (de) Gereinigtes protein mit angiogenischer wirkung und dessen herstellung.
DE69629075D1 (de) Zyklische Peptide mit fungizider Wirkung
NO940299L (no) Peptid med organbeskyttende aktivitet
MX9201416A (es) Peptidos y pseudopeptidos antitromboticos.
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
FI944802A7 (fi) HLE-proteiinien aktiivisuutta inhiboivat laktaamidipeptidit
ATE225804T1 (de) Zyklische peptide mit fungizider wirkung
DE69301468D1 (de) Peptide mit Bradykinin-antagonistischer Wirkung
ES2157523T3 (es) Solucion de dialisis peritoneal.
ATE90359T1 (de) Peptide.
DE69330268D1 (de) Hämoregulierende peptide
MX9803662A (es) Oligopeptidos novedosos, preparacion y uso de estos.
DE69002881D1 (de) Peptide und deren Benutzung.
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
DE69334281D1 (de) TCF-II enthaltende medizinische Zusammensetzung
ATE31418T1 (de) Arzneimittel, welche tripeptide enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee